KeyBanc analyst issues OVERWEIGHT recommendation for AMAT on February 13, 2026 11:16AM ET. The previous analyst recommendation was Overweight.AMAT was trading at $328.39 at issue of the analyst recommendation.The overall...
KeyBanc analyst issues OVERWEIGHT recommendation for ANET on February 13, 2026 11:26AM ET. The previous analyst recommendation was Overweight.ANET was trading at $135.12 at issue of the analyst recommendation.The overall...
KeyBanc analyst issues OVERWEIGHT recommendation for WMT on February 13, 2026 11:35AM ET. The previous analyst recommendation was Overweight.WMT was trading at $133.64 at issue of the analyst recommendation.The overall...
Piper Sandler analyst issues OVERWEIGHT recommendation for ANET on February 13, 2026 11:46AM ET. The previous analyst recommendation was Overweight.ANET was trading at $135.12 at issue of the analyst recommendation.The...
KGI Securities analyst issues OUTPERFORM recommendation for AMAT on February 13, 2026 09:50AM ET. AMAT was trading at $328.39 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Summit Insights Group analyst issues BUY recommendation for AMAT on February 13, 2026 12:44AM ET. The previous analyst recommendation was Hold.AMAT was trading at $328.39 at issue of the analyst...
Goldman Sachs analyst issues BUY recommendation for MSFT on February 12, 2026 11:50PM ET. The previous analyst recommendation was Buy.MSFT was trading at $401.84 at issue of the analyst recommendation.The...
B. Riley analyst issues BUY recommendation for MSA on February 12, 2026 01:48PM ET. The previous analyst recommendation was Buy.MSA was trading at $205.52 at issue of the analyst recommendation.The...
Barclays analyst issues OVERWEIGHT recommendation for MSI on February 12, 2026 12:59PM ET. The previous analyst recommendation was Overweight.MSI was trading at $421.13 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for TMHC on February 12, 2026 12:56PM ET. The previous analyst recommendation was Outperform.TMHC was trading at $65.7 at issue of the analyst recommendation.The...
